2019
DOI: 10.1016/j.fct.2019.05.019
|View full text |Cite
|
Sign up to set email alerts
|

Human CYP3A4-mediated toxification of the pyrrolizidine alkaloid lasiocarpine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
29
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 52 publications
2
29
0
Order By: Relevance
“…Although much research has focused on the identification of PA metabolites (Buhler and Kedzierski 1986 ; Fashe et al 2014 , 2015 ; Fu et al 2004a ), their quantification revealed that a large portion is still unknown. Furthermore, GSH-DHP conjugates like 7,9-diglutathionyl-6,7-dihydro-1-hydroymethyl-5H-pyrrolizidine (diGSH-DHP), and 9-glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizidine (monoGSH-DHP) suggested as biomarkers for in vitro metabolic activation were not detectable when CYP content is low—for instance when using S9 as metabolic system instead of microsomes, or were only detectable after long-term incubation (Ebmeyer et al 2019 ; Geburek et al 2020 ; Kolrep et al 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…Although much research has focused on the identification of PA metabolites (Buhler and Kedzierski 1986 ; Fashe et al 2014 , 2015 ; Fu et al 2004a ), their quantification revealed that a large portion is still unknown. Furthermore, GSH-DHP conjugates like 7,9-diglutathionyl-6,7-dihydro-1-hydroymethyl-5H-pyrrolizidine (diGSH-DHP), and 9-glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizidine (monoGSH-DHP) suggested as biomarkers for in vitro metabolic activation were not detectable when CYP content is low—for instance when using S9 as metabolic system instead of microsomes, or were only detectable after long-term incubation (Ebmeyer et al 2019 ; Geburek et al 2020 ; Kolrep et al 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…When ingested, PAs with an unsaturated bond in 1,2 position of the necine unit ( Fig. 1) (hereafter called unsaturated PAs) metabolically oxidize and react with proteins and nucleic acids [43][44][45][46] resulting in hepatotoxic, mutagenic and carcinogenic effects 16,37,41,[46][47][48][49][50] .…”
mentioning
confidence: 99%
“…Plants with high concentrations of unsaturated PAs are responsible for the death of cattle 18,55 . Toxic effects in humans such as hepatic sinusoidal obstruction syndrome and incidents of acute and subacute food poisoning with high morbidity and mortality have been reported from many countries 24,25,37,38,44,45,50,55,56 . The World Health Organization (WHO) recommends minimizing PA exposure to humans as much as possible 57 .…”
mentioning
confidence: 99%
“…The C-oxidation pathway is generally considered as the metabolic activation, which catalyzes the dehydrogenation of PAs to DHPAs (Mattocks and Jukes 1990). CYP3A and CYP2B subfamilies are responsible for the metabolic activation of toxic PAs in experimental animals Huan et al 1998a), while CYP3A4 isozyme predominately catalyzes the PA bioactivation in humans (Chung and Buhler 1994;Dueker et al 1992a;Ebmeyer et al 2019;Lin et al 2000;Miranda et al 1991;Williams et al 1989a). Using human liver microsomes and recombinant CYPs, Ruan et al investigated metabolic activation of different PAs and demonstrated that CYP1A1, CYP1A2, CYP2A6, CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 were responsible for the metabolic activation of retronecine/heliotridinetype PAs, while CYP3A4 and CYP3A5 predominantly mediated the metabolic activation of otonecine-type PAs (Ruan et al 2014b).…”
Section: Cytochrome P450 Enzymesmentioning
confidence: 99%